CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 2006; 56:106-130
doi: 10.3322/canjclin.56.2.106
© 2006 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.

Cancer Statistics, 2006

Ahmedin Jemal, DVM, PhD, Rebecca Siegel, MPH, Elizabeth Ward, PhD, Taylor Murray, Jiaquan Xu, Carol Smigal, MPH and Michael J. Thun, MD, MS


Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Xu is Epidemiologist, Mortality Statistics Branch, Division of Vital Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
Ms. Smigal is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice-President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,399,790 new cancer cases and 564,830 deaths from cancer are expected in the United States in 2006. When deaths are aggregated by age, cancer has surpassed heart disease as the leading cause of death for those younger than age 85 since 1999. Delay-adjusted cancer incidence rates stabilized in men from 1995 through 2002, but continued to increase by 0.3% per year from 1987 through 2002 in women. Between 2002 and 2003, the actual number of recorded cancer deaths decreased by 778 in men, but increased by 409 in women, resulting in a net decrease of 369, the first decrease in the total number of cancer deaths since national mortality record keeping was instituted in 1930. The death rate from all cancers combined has decreased by 1.5% per year since 1993 among men and by 0.8% per year since 1992 among women. The mortality rate has also continued to decrease for the three most common cancer sites in men (lung and bronchus, colon and rectum, and prostate) and for breast and colon and rectum cancers in women. Lung cancer mortality among women continues to increase slightly. In analyses by race and ethnicity, African American men and women have 40% and 18% higher death rates from all cancers combined than White men and women, respectively. Cancer incidence and death rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites. However, these groups generally have higher rates for stomach, liver, and cervical cancers than Whites. Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites. Progress in reducing the burden of suffering and death from cancer can be accelerated by applying existing cancer control knowledge across all segments of the population.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
Y. L. Choi, K. Takeuchi, M. Soda, K. Inamura, Y. Togashi, S. Hatano, M. Enomoto, T. Hamada, H. Haruta, H. Watanabe, et al.
Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer
Cancer Res., July 1, 2008; 68(13): 4971 - 4976.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Nocito, F. Dahm, W. Jochum, J. H. Jang, P. Georgiev, M. Bader, R. Graf, and P.-A. Clavien
Serotonin Regulates Macrophage-Mediated Angiogenesis in a Mouse Model of Colon Cancer Allografts
Cancer Res., July 1, 2008; 68(13): 5152 - 5158.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Dehm, L. J. Schmidt, H. V. Heemers, R. L. Vessella, and D. J. Tindall
Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
Cancer Res., July 1, 2008; 68(13): 5469 - 5477.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Bonome, D. A. Levine, J. Shih, M. Randonovich, C. A. Pise-Masison, F. Bogomolniy, L. Ozbun, J. Brady, J. C. Barrett, J. Boyd, et al.
A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer
Cancer Res., July 1, 2008; 68(13): 5478 - 5486.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
H. Sontheimer
An Unexpected Role for Ion Channels in Brain Tumor Metastasis
Experimental Biology and Medicine, July 1, 2008; 233(7): 779 - 791.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Taieb, J. Roignot, F. Andre, S. Garcia, B. Masson, A. Pierres, J.-L. Iovanna, and P. Soubeyran
ArgBP2-Dependent Signaling Regulates Pancreatic Cell Migration, Adhesion, and Tumorigenicity
Cancer Res., June 15, 2008; 68(12): 4588 - 4596.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. D. Cowden Dahl, J. Symowicz, Y. Ning, E. Gutierrez, D. A. Fishman, B. P. Adley, M. S. Stack, and L. G. Hudson
Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells
Cancer Res., June 15, 2008; 68(12): 4606 - 4613.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. D. Peacock and D. N. Watkins
Cancer Stem Cells and the Ontogeny of Lung Cancer
J. Clin. Oncol., June 10, 2008; 26(17): 2883 - 2889.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. B. Schwarzberg, C. B. Alexander, D. J. DeAngelo, and S. M. Helfgott
A Joint Venture
N. Engl. J. Med., June 5, 2008; 358(23): 2496 - 2501.
[Full Text] [PDF]

Home page
 JAMAHome page
B. Pasche
Familial Colorectal Cancer: A Genetics Treasure Trove for Medical Discovery
JAMA, June 4, 2008; 299(21): 2564 - 2565.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
N. W. Wilkinson, J. Howe, G. Gay, L. Patel-Parekh, C. Scott-Conner, and J. Donohue
Differences in the Pattern of Presentation and Treatment of Proximal and Distal Gastric Cancer: Results of the 2001 Gastric Patient Care Evaluation
Ann. Surg. Oncol., June 1, 2008; 15(6): 1644 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 American Journal of Men's HealthHome page
C. A. Engstrom
Hot Flashes in Prostate Cancer: State of the Science
American Journal of Men's Health, June 1, 2008; 2(2): 122 - 132.
[Abstract] [PDF]

Home page
 Jpn J Clin OncolHome page
H. S. Kim, N.-H. Park, H. H. Chung, J. W. Kim, Y.-S. Song, and S.-B. Kang
Are Three Additional Cycles of Chemotherapy Useful in Patients with Advanced-stage Epithelial Ovarian Cancer After a Complete Response to Six Cycles of Intravenous Adjuvant Paclitaxel and Carboplatin?
Jpn. J. Clin. Oncol., June 1, 2008; 38(6): 445 - 450.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H.-L. Chang, Y.-C. Wu, J.-H. Su, Y.-T. Yeh, and S.-S. F. Yuan
Protoapigenone, a Novel Flavonoid, Induces Apoptosis in Human Prostate Cancer Cells through Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase 1/2
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 841 - 849.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
A. Sanabria, A. L. Carvalho, J. G. Vartanian, J. Magrin, M. K. Ikeda, and L. P. Kowalski
Validation of the Washington University Head and Neck Comorbidity Index in a Cohort of Older Patients
Arch Otolaryngol Head Neck Surg, June 1, 2008; 134(6): 603 - 607.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
G. J. Mize, W. Wang, and T. K. Takayama
Prostate-Specific Kallikreins-2 and -4 Enhance the Proliferation of DU-145 Prostate Cancer Cells through Protease-Activated Receptors-1 and -2
Mol. Cancer Res., June 1, 2008; 6(6): 1043 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
H. T. Tan, S. Tan, Q. Lin, T. K. Lim, C. L. Hew, and M. C. M. Chung
Quantitative and Temporal Proteome Analysis of Butyrate-treated Colorectal Cancer Cells
Mol. Cell. Proteomics, June 1, 2008; 7(6): 1174 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. K. Nayak, H. J. Hathaway, C. Ramesh, J. B. Arterburn, D. Dai, L. A. Sklar, J. P. Norenberg, and E. R. Prossnitz
Preclinical Development of a Neutral, Estrogen Receptor-Targeted, Tridentate 99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers
J. Nucl. Med., June 1, 2008; 49(6): 978 - 986.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Li, R. Li, J. R. Grandis, and D. E. Johnson
Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells
Mol. Cancer Ther., June 1, 2008; 7(6): 1647 - 1655.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Ali, S. Banerjee, A. Ahmad, B. F. El-Rayes, P. A. Philip, and F. H. Sarkar
Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer
Mol. Cancer Ther., June 1, 2008; 7(6): 1708 - 1719.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. R. Shoemaker, M. J. Mitten, J. Adickes, S. Ackler, M. Refici, D. Ferguson, A. Oleksijew, J. M. O'Connor, B. Wang, D. J. Frost, et al.
Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
Clin. Cancer Res., June 1, 2008; 14(11): 3268 - 3277.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. J. French, D. J. Sargent, L. J. Burgart, N. R. Foster, B. F. Kabat, R. Goldberg, L. Shepherd, H. E. Windschitl, and S. N. Thibodeau
Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
Clin. Cancer Res., June 1, 2008; 14(11): 3408 - 3415.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
E. J. Akins and P. Dubey
Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 180S - 195S.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. Li, T. D. Thompson, J. W. Miller, L. A. Pollack, and S. L. Stewart
Cancer Incidence Among Children and Adolescents in the United States, 2001-2003
Pediatrics, June 1, 2008; 121(6): e1470 - e1477.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. A. Morales, D. Gutman, K. P. Lee, and L. H. Boise
BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma
Blood, May 15, 2008; 111(10): 5152 - 5162.
[Abstract] [Full Text] [PDF]

Home page
 PsychosomaticsHome page
W. F. Pirl, J. S. Temel, A. Billings, C. Dahlin, V. Jackson,, H. G. Prigerson, J. Greer, and T. J. Lynch
Depression After Diagnosis of Advanced Non-Small Cell Lung Cancer and Survival: A Pilot Study
Psychosomatics, May 1, 2008; 49(3): 218 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. S Al-Zahrani, M.-E. M Abouzied, S. A. Salam, G. Mohamed, A. Rifai, A. Al Sugair, and T. Amin
The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer
Eur. J. Endocrinol., May 1, 2008; 158(5): 683 - 689.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. J. Menezes, R. T. Cheney, A. Husain, M. Tretiakova, G. Loewen, C. S. Johnson, V. Jayaprakash, K. B. Moysich, R. Salgia, and M. E. Reid
Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung Tissue
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1104 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. Liakakos and E. G. Lykoudis
Local Control, Aggressive Surgery, and Overall Survival for Breast Cancer
Ann. Surg. Oncol., May 1, 2008; 15(5): 1544 - 1546.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
V. G. Kaklamani, M. Sadim, A. Hsi, K. Offit, C. Oddoux, H. Ostrer, H. Ahsan, B. Pasche, and C. Mantzoros
Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk
Cancer Res., May 1, 2008; 68(9): 3178 - 3184.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D A Vallera, B J Stish, Y Shu, H Chen, A Saluja, D J Buchsbaum, and S M Vickers
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
Gut, May 1, 2008; 57(5): 634 - 641.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. E. Rosenberg, S. Halabi, B. L. Sanford, A. L. Himelstein, J. N. Atkins, R. J. Hohl, F. Millard, D. F. Bajorin, E. J. Small, and For the Cancer and Leukemia Group B
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
Ann. Onc., May 1, 2008; 19(5): 946 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Liby, C. C. Black, D. B. Royce, C. R. Williams, R. Risingsong, M. M. Yore, X. Liu, T. Honda, G. W. Gribble, W. W. Lamph, et al.
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis
Mol. Cancer Ther., May 1, 2008; 7(5): 1251 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
X. M. Zhang, H. L. Zhang, D. Yu, Y. Dai, D. Bi, M. R. Prince, and C. Li
3-T MRI of Rectal Carcinoma: Preoperative Diagnosis, Staging, and Planning of Sphincter-Sparing Surgery
Am. J. Roentgenol., May 1, 2008; 190(5): 1271 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Kawanishi, Y. Matsui, M. Ito, J. Watanabe, T. Takahashi, K. Nishizawa, H. Nishiyama, T. Kamoto, Y. Mikami, Y. Tanaka, et al.
Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer
Clin. Cancer Res., May 1, 2008; 14(9): 2579 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Reiser, J. Wang, L. Chong, W. J. Watkins, A. S. Ray, R. Shibata, G. Birkus, T. Cihlar, S. Wu, B. Li, et al.
GS-9219--A Novel Acyclic Nucleotide Analogue with Potent Antineoplastic Activity in Dogs with Spontaneous Non-Hodgkin's Lymphoma
Clin. Cancer Res., May 1, 2008; 14(9): 2824 - 2832.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
C. Ferreiro-Arguelles, L. Jimenez-Juan, J. M. Martinez-Salazar, J. L. Cervera-Rodilla, M. M. Martinez-Perez, J. Cubero-Carralero, S. Gonzalez-Cabestreros, M. A. Lopez-Pino, and J. M. Fernandez-Gallardo
CT Findings after Laryngectomy
RadioGraphics, May 1, 2008; 28(3): 869 - 882.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-J. Yen, J. G. Izzo, D.-F. Lee, S. Guha, Y. Wei, T.-T. Wu, C.-T. Chen, H.-P. Kuo, J.-M. Hsu, H.-L. Sun, et al.
Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma
Cancer Res., April 15, 2008; 68(8): 2632 - 2640.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Leng, C. A. Stidley, R. Willink, A. Bernauer, K. Do, M. A. Picchi, X. Sheng, M. A. Frasco, D. Van Den Berg, F. D. Gilliland, et al.
Double-Strand Break Damage and Associated DNA Repair Genes Predispose Smokers to Gene Methylation
Cancer Res., April 15, 2008; 68(8): 3049 - 3056.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Verma, S. Guha, P. Diagaradjane, A. B. Kunnumakkara, A. M. Sanguino, G. Lopez-Berestein, A. K. Sood, B. B. Aggarwal, S. Krishnan, J. G. Gelovani, et al.
Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer
Clin. Cancer Res., April 15, 2008; 14(8): 2476 - 2483.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. A. Traina, M. Theodoulou, K. Feigin, S. Patil, K. L. Tan, C. Edwards, U. Dugan, L. Norton, and C. Hudis
Phase I Study of a Novel Capecitabine Schedule Based on the Norton-Simon Mathematical Model in Patients With Metastatic Breast Cancer
J. Clin. Oncol., April 10, 2008; 26(11): 1797 - 1802.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
Y. Gao, W.-X. Zhong, D.-B. Mu, Y.-P. Yuan, Y.-H. Zhang, J.-M. Yu, L.-P. Sun, L. Wang, Y.-H. Li, J.-B. Zhang, et al.
Distributions of Angiogenesis and Lymphangiogenesis in Gastrointestinal Intramucosal Tumors
Ann. Surg. Oncol., April 1, 2008; 15(4): 1117 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. Kobayashi, K. Sugihara, H. Uetake, T. Higuchi, M. Yasuno, M. Enomoto, H. Kuramochi, H.-J. Lenz, K. D. Danenberg, and P. V. Danenberg
Messenger RNA Expression of Vascular Endothelial Growth Factor and Its Receptors in Primary Colorectal Cancer and Corresponding Liver Metastasis
Ann. Surg. Oncol., April 1, 2008; 15(4): 1232 - 1238.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. Harissis and M. Fatouros
Nodal Micrometastases Status--Will It Influence Decisions on Surgical and Adjuvant Treatment for Breast Cancer?
Ann. Surg. Oncol., April 1, 2008; 15(4): 1256 - 1257.
[Full Text] [PDF]

Home page
 GutHome page
L Ricci-Vitiani, A Pagliuca, E Palio, A Zeuner, and R De Maria
Colon cancer stem cells
Gut, April 1, 2008; 57(4): 538 - 548.
[Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
B. P. van Putte, M. Grootenboers, W.-J. van Boven, J. M. H. Hendriks, P. E. Y. van Schil, G. Guetens, G. De Boeck, G. Pasterkamp, F. Schramel, and G. Folkerts
Pharmacokinetics of Gemcitabine when Delivered by Selective Pulmonary Artery Perfusion for the Treatment of Lung Cancer
Drug Metab. Dispos., April 1, 2008; 36(4): 676 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Vonlaufen, S. Joshi, C. Qu, P. A. Phillips, Z. Xu, N. R. Parker, C. S. Toi, R. C. Pirola, J. S. Wilson, D. Goldstein, et al.
Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
Cancer Res., April 1, 2008; 68(7): 2085 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. B. Pearson, A. McCarthy, C. M.P. Collins, A. Ashworth, and A. R. Clarke
Lkb1 Deficiency Causes Prostate Neoplasia in the Mouse
Cancer Res., April 1, 2008; 68(7): 2223 - 2232.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. L. Martinez-Torrecuadrada, L. H. Cheung, P. Lopez-Serra, R. Barderas, M. Canamero, S. Ferreiro, M. G. Rosenblum, and J. I. Casal
Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis
Mol. Cancer Ther., April 1, 2008; 7(4): 862 - 873.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. N. Chi, S. L. Ellard, S. J. Hotte, P. Czaykowski, M. Moore, J. D. Ruether, A. J. Schell, S. Taylor, C. Hansen, I. Gauthier, et al.
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer
Ann. Onc., April 1, 2008; 19(4): 746 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Huser, I. Crha, P. Ventruba, R. Hudecek, J. Zakova, L. Smardova, Z. Kral, and J. Jarkovsky
Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients
Hum. Reprod., April 1, 2008; 23(4): 863 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Verma, S. Guha, H. Wang, J. Y. Fok, D. Koul, J. Abbruzzese, and K. Mehta
Tissue Transglutaminase Regulates Focal Adhesion Kinase/AKT Activation by Modulating PTEN Expression in Pancreatic Cancer Cells
Clin. Cancer Res., April 1, 2008; 14(7): 1997 - 2005.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. P. Morton, D. S. Klimstra, M. E. Mongeau, and B. C. Lewis
Trp53 Deletion Stimulates the Formation of Metastatic Pancreatic Tumors
Am. J. Pathol., April 1, 2008; 172(4): 1081 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. K. Hoang, L. F. Hoagland, R. E. Coleman, A. D. Coan, J. E. Herndon II, and E. F. Patz Jr
Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non-Small-Cell Lung Carcinoma
J. Clin. Oncol., March 20, 2008; 26(9): 1459 - 1464.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
T. J. Wilt, R. MacDonald, I. Rutks, T. A. Shamliyan, B. C. Taylor, and R. L. Kane
Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer
Ann Intern Med, March 18, 2008; 148(6): 435 - 448.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. Weichert, A. Roske, S. Niesporek, A. Noske, A.-C. Buckendahl, M. Dietel, V. Gekeler, M. Boehm, T. Beckers, and C. Denkert
Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
Clin. Cancer Res., March 15, 2008; 14(6): 1669 - 1677.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Gu, X. Song, Y. Dong, H. Cai, E. Walters, R. Zhang, X. Pang, T. Xie, Y. Guo, R. Sridhar, et al.
Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo
Clin. Cancer Res., March 15, 2008; 14(6): 1840 - 1848.
[Abstract] [Full Text]